Sonnet Biotherapeutics HoldiSONN
13F holders, Q3 2024 (September 30)2holders
$6.70avg. 13F price*
At the end of Q3 2024, 2 institutions reported holding Sonnet Biotherapeutics Holdi (SONN) in their 13F filings. The largest holders were Tower Research Capital LLC (TRC) ($3K) and BlackRock, Inc. ($435).
- Company
- Sonnet Biotherapeutics Holdi
- CUSIP
- 83548R402
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $3K |
| Exits | 0 | $0 |
Ownership 2 holders
| Tower Research Capital LLC (TRC) | 0.00% | New | 378 | $3K |
| BlackRock, Inc. | 0.00% | — | 65 | $435 |
"% of holder's portfolio" is SONN's weight in each manager's 13F, not the share of Sonnet Biotherapeutics Holdi the manager owns.